Page last updated: 2024-08-23

staurosporine and hymenialdisine

staurosporine has been researched along with hymenialdisine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, K; Concepción, GP; Feldberg, LR; Greenstein, M; Harper, MK; Ireland, CM; Kim, SC; Mallon, R; Mangalindan, GC; Tasdemir, D; Wojciechowicz, D1
Flajolet, M; Greengard, P; Meijer, L1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Kato, M; Kawaguchi, M; Kojima, H; Nagano, T; Okabe, T; Tanaka, A; Terai, T; Tsuganezawa, K; Utata, R1
Jagarlapudi, SA; Sinha, BN; Tajne, S; Vadivelan, S1
Hoda, N; Maqbool, M; Mobashir, M1
Agrawal, K; Annadurai, N; Das, V; Džubák, P; Hajdúch, M1

Reviews

3 review(s) available for staurosporine and hymenialdisine

ArticleYear
Pharmacological inhibitors of glycogen synthase kinase 3.
    Trends in pharmacological sciences, 2004, Volume: 25, Issue:9

    Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship

2004
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors

2016
Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
    Cellular and molecular life sciences : CMLS, 2017, Volume: 74, Issue:22

    Topics: Alzheimer Disease; Antigens, Bacterial; Azepines; Bacterial Proteins; Humans; Methylene Blue; Neurons; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyridines; Pyrroles; Staurosporine; tau Proteins

2017

Other Studies

4 other study(ies) available for staurosporine and hymenialdisine

ArticleYear
Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1).
    Journal of medicinal chemistry, 2002, Jan-17, Volume: 45, Issue:2

    Topics: Animals; Antineoplastic Agents; Azepines; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Philippines; Phosphorylation; Porifera; Protein Serine-Threonine Kinases; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured

2002
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Jul-01, Volume: 18, Issue:13

    Topics: Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Evaluation, Preclinical; Fluorescence Polarization; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Kinetics; MAP Kinase Kinase Kinase 5; Models, Chemical; Molecular Conformation; Protein Binding; Protein Kinase Inhibitors; Spectrometry, Fluorescence; Staurosporine

2008
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:6

    Topics: Algorithms; Computer Simulation; Databases, Factual; Drug Design; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Models, Chemical; Models, Molecular; Molecular Structure; Oxazines; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Stereoisomerism; Structure-Activity Relationship

2009